NANTES UNIVERSITE

Their core work

Nantes Université is a major French research university with deep strengths in biomedical sciences — particularly immunology, transplantation medicine, and advanced cell therapies — alongside marine biotechnology and materials science. Their research teams develop regenerative medicine approaches using stem cells and regulatory T cells, work on precision diagnostics for organ transplant rejection, and explore microalgae-based biorefinery processes. They also contribute to robotics, photonics, and digital innovation projects, making them a versatile academic partner capable of bridging fundamental biology with applied engineering challenges.

What they specialise in

How they've shifted over time

In the early H2020 period (2015–2018), Nantes Université's portfolio was broad and exploratory — spanning aquaculture sustainability, fibre optic sensors, robotics for manufacturing, and marine biodiversity research. From 2019 onward, a sharp convergence toward biomedical innovation is visible: transplantation immunology, gene therapy, stem cell-based ATMPs, and regulatory T cell engineering dominate the recent project portfolio. This shift reflects a deliberate institutional strategy to become a European hub for advanced cell and gene therapies.

Nantes Université is consolidating around precision immunology and cell-based therapies (ATMPs), making them an increasingly focused partner for biomedical consortia in Horizon Europe.

How they like to work

Nantes Université overwhelmingly participates as a partner (24 of 33 projects) rather than leading consortia, with only 3 coordinator roles — suggesting they contribute deep scientific expertise within larger teams rather than driving project management. Their 376 unique partners across 42 countries indicate a vast, diverse network rather than a tight cluster of repeat collaborators. This makes them an accessible and experienced consortium member who integrates well into international teams but is unlikely to take on coordination responsibilities unless the topic aligns closely with their core strengths.

With 376 unique consortium partners spanning 42 countries, Nantes Université has one of the broadest collaboration networks among French universities in H2020. Their partnerships extend well beyond Europe into Africa and Brazil, particularly through marine and humanities projects like PADDLE and SLAFNET.

What sets them apart

Nantes Université sits at a rare intersection of transplantation immunology, advanced cell therapies, and marine biotechnology — a combination almost no other European university offers under one roof. Their biomedical cluster is particularly strong: five concurrent projects on immune regulation and ATMPs creates critical mass that attracts top-tier consortia. For consortium builders, they bring the dual advantage of deep wet-lab biology expertise and a 42-country network that simplifies partner recruitment.

Highlights from their portfolio

• SUMMIT
  Their largest coordinated project (EUR 2M ERC grant) developing ultrasensitive NMR spectroscopy — demonstrates capacity to lead ambitious fundamental research.
• RESHAPE
  Largest single funding (EUR 2M) in a high-impact health project engineering next-generation regulatory T cells using CRISPR/Cas9 and human-on-chip technology.
• EuQu
  Unexpected for a science-heavy university: a EUR 2.4M humanities project studying the Qur'an in European culture 1150–1850, showing genuine multidisciplinary breadth.